PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 291,360 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 291,360 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 291,360 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $720,000 | -60.2% | 291,360 | -49.3% | 0.05% | -11.9% |
| Q3 2020 | $1,809,000 | -26.3% | 574,423 | -31.9% | 0.06% | -6.3% |
| Q2 2020 | $2,453,000 | +36.5% | 842,950 | +32.3% | 0.06% | +34.0% |
| Q1 2020 | $1,797,000 | -71.5% | 637,311 | -67.2% | 0.05% | -47.2% |
| Q4 2019 | $6,308,000 | +85.6% | 1,943,774 | +23.5% | 0.09% | +122.5% |
| Q3 2019 | $3,399,000 | -22.0% | 1,573,780 | +13.5% | 0.04% | -52.9% |
| Q2 2019 | $4,355,000 | -12.3% | 1,386,885 | +3.9% | 0.08% | -15.0% |
| Q1 2019 | $4,966,000 | – | 1,334,943 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |